NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Athyrium Capital Management

Athyrium Capital Management

New York City, New Yorkathyrium.com

Overview

Athyrium Capital Management is a specialized asset management firm that focuses on investment opportunities in the global healthcare and life sciences sectors, including pharmaceuticals, medical devices, and healthcare services.

Year Founded

2008

AUM

$2.9B

Portfolio Companies

31

Investments

Athyrium Capital Management investments
CompanyDateStageLead
OrangeTwistDec 2025StrategicCo-investor
US WorldMeds, LLCAug 2025DebtCo-investor
Choice Health at HomeNov 2024DebtCo-investor
Vita HealthJan 2024Series ACo-investor
RVL PharmaceuticalsAug 2023Private PlacementCo-investor

Key People

Jeffrey Ferrell

Managing Partner

Courtney Paul

Associate General Counsel Vice President, Investor Relations

April Pun

Principal

Michelle Fang Jordan

Principal

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersNew York City, New York
Year Founded2008
AUM$2.9B

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.